ROMAN: PHASE 3 TRIAL OF AVASOPASEM MANGANESE (GC4419) FOR SEVERE ORAL MUCOSITIS (SOM) IN PATIENTS RECEIVING CHEMORADIOTHERAPY (CRT) FOR LOCALLY ADVANCED HEAD AND NECK CANCER ( LAHNC)-MedSci.cn

ROMAN: PHASE 3 TRIAL OF AVASOPASEM MANGANESE (GC4419) FOR SEVERE ORAL MUCOSITIS (SOM) IN PATIENTS RECEIVING CHEMORADIOTHERAPY (CRT) FOR LOCALLY ADVANCED HEAD AND NECK CANCER ( LAHNC)

Cullen, E; Brown, H; Carringer, J; Amado, A; Pitre, L; Anderson, C

ONCOLOGY NURSING FORUM, 2023; 50 (2):

科室
- - 订阅+
  - 更多科室
工具
服务